Business Wire - Merck Serono and Flamel to Collaborate on an Extended Release Formulation for Therapeutic Proteins
Tuesday, December 2nd, 2008 Flamel’s Medusa([R]) technology designed to allow less frequent administration of therapeutic proteins and peptides
LYON, France — Flamel Technologies (Nasdaq:FLML) today announced that it has entered into a collaboration with Merck Serono, a division of Merck KGaA, to investigate the applicability of Flamel’s Medusa([R]) technology for the extended release of a therapeutic protein of Merck Serono’s portfolio. Unde…
